iO Associates
Executive Vice President of Regulatory Affairs
iO Associates, Tate, Georgia, United States, 30177
iO Associates is supporting a clinical-stage biotech with programs in
Phase 2/3
and a multi-year runway in their search for an
Executive Vice President, Regulatory Affairs.
You will be the senior-most regulatory leader, reporting to the CMO and sitting on core program teams. You'll set the end-to-end regulatory roadmap and lead high-stakes interactions with global health authorities to secure and maintain market access.
Key responsibilities
Define and drive
global regulatory strategy
across development and pre-/post-approval phases. Serve as primary interface with
FDA
and partner on EMA/other agencies; plan and lead key meetings. Orchestrate high-quality submissions ( IND/CTA NDA/MAA , labeling, briefing packages) with Clinical,
CMC , Safety, and Biometrics. Build, mentor, and scale the Regulatory Affairs function; establish SOPs, policies, and best practices. Anticipate/mitigate regulatory risks; shape positions on evolving guidelines and the competitive landscape. Contribute to corporate planning, governance, and selective BD diligence. Qualifications
20+ years
in pharma/biotech;
15+ years
leading Regulatory Affairs for
small-molecule
programs. Proven record of
US/EU submissions and approvals ; confident leading FDA/EMA engagements. Late-stage ( Phase 3/pivotal ) experience; eCTD/CTD fluency. Strong cross-functional leadership with Clinical, CMC, Safety; able to build teams and systems in a lean environment. Location & work style
California (hybrid)
with periodic on-site time
Phase 2/3
and a multi-year runway in their search for an
Executive Vice President, Regulatory Affairs.
You will be the senior-most regulatory leader, reporting to the CMO and sitting on core program teams. You'll set the end-to-end regulatory roadmap and lead high-stakes interactions with global health authorities to secure and maintain market access.
Key responsibilities
Define and drive
global regulatory strategy
across development and pre-/post-approval phases. Serve as primary interface with
FDA
and partner on EMA/other agencies; plan and lead key meetings. Orchestrate high-quality submissions ( IND/CTA NDA/MAA , labeling, briefing packages) with Clinical,
CMC , Safety, and Biometrics. Build, mentor, and scale the Regulatory Affairs function; establish SOPs, policies, and best practices. Anticipate/mitigate regulatory risks; shape positions on evolving guidelines and the competitive landscape. Contribute to corporate planning, governance, and selective BD diligence. Qualifications
20+ years
in pharma/biotech;
15+ years
leading Regulatory Affairs for
small-molecule
programs. Proven record of
US/EU submissions and approvals ; confident leading FDA/EMA engagements. Late-stage ( Phase 3/pivotal ) experience; eCTD/CTD fluency. Strong cross-functional leadership with Clinical, CMC, Safety; able to build teams and systems in a lean environment. Location & work style
California (hybrid)
with periodic on-site time